Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yael Flamand

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805Wendy J Bottinor, Yael Flamand, Naomi B Haas, et al.
Transfusion|October 11, 2023
Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative studyRichard M Kaufman, Denese C Marks, Yael Flamand, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
Pediatric Blood & Cancer|July 17, 2023
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL ConsortiumJennifer J G Welch, Yael Flamand, Kristen E Stevenson, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
BMC Cancer|November 7, 2014
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapyEdwin Choy, James E Butrynski, David C Harmon, et al.
Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
The Journal of Biological Chemistry|December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductaseLisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
JAMA Network Open|May 14, 2025
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic LeukemiaElena J Ladas, Haiyang Sheng, Uma H Athale, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Cardiovascular Implications of Vascular Endothelial Growth Factor Inhibition Among Adolescents/Young Adults in ECOG-ACRIN E2805Wendy J Bottinor, Yael Flamand, Naomi B Haas, et al.
Transfusion|October 11, 2023
Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative studyRichard M Kaufman, Denese C Marks, Yael Flamand, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
Pediatric Blood & Cancer|July 17, 2023
Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL ConsortiumJennifer J G Welch, Yael Flamand, Kristen E Stevenson, et al.
Blood Advances|November 15, 2024
Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemiaMarlise R Luskin, Shai Shimony, Julia Keating, et al.
BMC Cancer|November 7, 2014
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapyEdwin Choy, James E Butrynski, David C Harmon, et al.
Cancer|December 25, 2014
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcomaEdwin Choy, Yael Flamand, Sriram Balasubramanian, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
The Journal of Biological Chemistry|December 26, 2021
The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductaseLisa N Heppler, Sanaz Attarha, Rosanne Persaud, et al.
JAMA Network Open|May 14, 2025
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic LeukemiaElena J Ladas, Haiyang Sheng, Uma H Athale, et al.
Pageof 4